Inside Recursion’s Pipeline: Najat Khan On AI, Data Science And Biotech Innovation

 
• By David Wild

In Vivo caught up with Najat Khan, chief R&D and commercial officer at Recursion since mid-2024, about her new roles, the special combination with Exscientia and the company's clinical pipeline.

Najat Khan
Najat Khan is Recursion’s new chief R&D and chief commercial officer. • Source: Recursion

More from C-Suite Speaks

More from Market Intelligence